▸ 21 Sep 2026, 18:18 Notification regarding unquoted securities - AXE Securities Administration
▸ 17 Sep 2026, 08:57 Notice Required Under ASX Listing Rule 3.13.1 Meetings & Governance
▸ 14 Sep 2026, 09:39 Archer launches Quantum Commercial Pilot Company Update
▸ 4 Sep 2026, 17:16 Notice under section 708A of the Corporations Act Securities Administration
▸ 4 Sep 2026, 17:09 Change of Director's Interest Notice - GE BH Director Interests
▸ 4 Sep 2026, 09:46 Application for quotation of securities - AXE Securities Administration
▸ 4 Sep 2026, 09:40 Notification regarding unquoted securities - AXE Securities Administration
▸ 4 Sep 2026, 09:20 Prospectus Capital Raising
▸ 27 Aug 2026, 09:41 2026 Corporate Governance Statement and Appendix 4G Company Administration
▸ 27 Aug 2026, 09:30 Appendix 4E and 2026 Annual Report Financial Results
▸ 18 Aug 2026, 14:12 Results of General Meeting Meetings & Governance
▸ 13 Aug 2026, 09:27 Early Pre-Pilot Study Advances Potassium Biosensor Company Update
▸ 10 Aug 2026, 09:53 Application for quotation of securities - AXE Securities Administration
▸ 10 Aug 2026, 09:50 Results of Share Purchase Plan Capital Raising
▸ 29 Jul 2026, 09:32 Biochip Advances Towards Clinical-Ready Device Development Company Update
▸ 17 Jul 2026, 09:17 Notice of General Meeting/Proxy Form Meetings & Governance
▸ 10 Jul 2026, 09:07 Dispatch of Share Purchase Plan Offer Booklet Capital Raising
▸ 9 Jul 2026, 09:46 Completion of A$6.86m Tranche 1 Placement, s708A Notice Securities Administration
▸ 9 Jul 2026, 09:38 Application for quotation of securities - AXE Securities Administration
▸ 9 Jul 2026, 09:23 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 3 Jul 2026, 16:05 AXE to host webinar - IonQ Strategic Partnership and SPP Capital Raising
▸ 3 Jul 2026, 10:02 Proposed issue of securities - AXE Securities Administration
▸ 3 Jul 2026, 10:02 Presentation - Bringing Quantum Computing to Australia Presentations
▸ 3 Jul 2026, 10:02 Archer Completes $7m Placement and Launches SPP Offer Capital Raising
▸ 1 Jul 2026, 09:27 Archer enters strategic agreement with quantum leader, IonQ Company Update
▸ 1 Jul 2026, 09:03 Trading Halt Trading Halt / Suspension
▸ 26 Jun 2026, 17:04 Notification of cessation of securities - AXE Securities Administration
▸ 15 Jun 2026, 09:38 AXE advances quantum strategy amid growing global momentum Company Update
▸ 4 Jun 2026, 13:56 Archer QML Project achieves key milestones Company Update
▸ 21 May 2026, 16:41 Notification of cessation of securities - AXE Securities Administration
▸ 15 May 2026, 09:20 Biosensor beta prototype and manufacturing pathway advanced Company Update
▸ 12 May 2026, 09:17 Archer strengthens pathway to quantum device manufacturing Company Update
▸ 4 May 2026, 09:24 Archer to host quarterly update investor webinar Presentations
▸ 29 Apr 2026, 09:31 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 22 Apr 2026, 17:37 Notification of cessation of securities - AXE Securities Administration
▸ 7 Apr 2026, 10:30 Biochip advances toward beta prototype & clinical validation Company Update
▸ 18 Mar 2026, 09:19 Archer to commence QML simulations and benchmarking Company Update
▸ 4 Mar 2026, 09:14 1H FY26 Update - Presentation Financial Results
▸ 25 Feb 2026, 09:45 Appendix 4D and Half Year Financial Report Financial Results
▸ 12 Feb 2026, 09:30 Quantum program advances with ecosystem-led execution Company Update
▸ 30 Jan 2026, 09:21 Archer develops early Biochip prototype Company Update
▸ 29 Jan 2026, 10:39 Investor Webinar - Presentation Presentations
▸ 29 Jan 2026, 09:22 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 22 Jan 2026, 08:25 Archer to host quarterly update investor webinar Company Administration
▸ 9 Jan 2026, 09:26 Letter to Shareholders Letters & Addresses
▸ 1 Dec 2025, 14:32 Final Director's Interest Notice - KW Director Interests
▸ 1 Dec 2025, 14:32 Initial Director's Interest Notice - AJ Director Interests
▸ 1 Dec 2025, 14:31 Archer Board Changes Company Administration
▸ 20 Nov 2025, 18:28 Change of Director's Interest Notice - GE Director Interests
▸ 20 Nov 2025, 18:26 Notification regarding unquoted securities - AXE Securities Administration
▸ 20 Nov 2025, 12:13 Results of 2025 Annual General Meeting Meetings & Governance
▸ 20 Nov 2025, 10:14 AGM Presentation Presentations
▸ 20 Nov 2025, 10:12 Chair's 2025 AGM address Letters & Addresses
▸ 20 Nov 2025, 08:30 AXE achieves readout milestone towards qubit demonstration Company Update
▸ 10 Nov 2025, 09:11 AXE & CSIRO - Quantum Machine Learning for fraud detection Company Update
▸ 3 Nov 2025, 09:48 Notification of cessation of securities - AXE Securities Administration
▸ 29 Oct 2025, 09:17 Silicon Biochip meets performance and clinical requirements Company Update
▸ 27 Oct 2025, 08:23 Quarterly Activities/Appendix 4C Cash Flow Report Quarterly Reports
▸ 22 Oct 2025, 08:27 Presentation - Semiconductor Australia 2025 Presentations
▸ 21 Oct 2025, 16:19 Notice of Annual General Meeting/Proxy Form Meetings & Governance
▸ 17 Oct 2025, 09:26 Archer and Emergence partner to pursue graphene quantum tech Company Update
▸ 15 Oct 2025, 12:45 AXE builds on EDMR breakthrough to advance qubit development Company Update
▸ 19 Sep 2025, 08:25 Notice Required Under ASX Listing Rule 3.13.1 Meetings & Governance
▸ 11 Sep 2025, 08:27 Investor Presentation - September 2025 Presentations
▸ 8 Sep 2025, 16:40 Notification regarding unquoted securities - AXE Securities Administration
▸ 1 Sep 2025, 08:29 Archer Strengthens Biochip Commercialisation Path Company Update
▸ 28 Aug 2025, 14:20 2025 Corporate Governance Statement and Appendix 4G Company Administration
▸ 28 Aug 2025, 14:20 2025 Annual Report Financial Results
▸ 28 Aug 2025, 14:16 FY25 Results and Appendix 4E Financial Results
▸ 12 Aug 2025, 08:39 AXE to Unlock Scalable Potassium Sensor Production with IMEC Company Update